<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">US Food and Drug Administration (FDA) has approved a test that qualitatively identifies immunoglobulin (Ig)M and IgG antibodies against SARS-CoV-2 in serum or plasma [
 <xref ref-type="bibr" rid="CR25">25</xref>]. Serologic screening is an important tool to understand population immunity and distinguish individuals who are at lower risk for reinfection.
</p>
